Intended Parents

IVF After Cancer Treatment: Fertility, Success Rates and When Surrogacy May Be the Better Option

IVF after cancer treatment is possible for many intended parents.

Whether it is an option for you depends on how cancer and its treatment affected your ovaries and reproductive organs, as well as whether your doctors consider pregnancy safe.

You may be able to create embryos but be unable to safely carry a pregnancy, or treatment may have reduced your ability to produce eggs.

If carrying is the main concern, gestational surrogacy may give you a way to use embryos you already have or create through IVF.

Can You Do IVF After Cancer Treatment?

Yes, you may be able to do IVF after cancer treatment.

A fertility specialist will look at your remaining ovarian reserve, reproductive anatomy, cancer treatment history and medical clearance to determine whether IVF with your own eggs is likely to be an option.

Chemotherapy, radiation and ovarian surgery can reduce the number of eggs available for IVF.

Treatment involving the uterus or cervix can create a different problem: you may still be able to create embryos but have difficulty carrying a pregnancy or be advised not to become pregnant.

Your options may also depend on whether you pursued fertility preservation before cancer treatment.

If you froze eggs or embryos before chemotherapy, radiation or surgery, you may be able to use them even if your current ovarian reserve is low.

Regular periods after treatment don’t necessarily mean fertility has returned to its previous level. Menstrual cycles can resume despite diminished ovarian reserve, and some cancer survivors experience menopause earlier than they otherwise would have.

A reproductive endocrinologist, preferably one with oncofertility experience, can assess your current fertility.

Your oncologist can address the separate questions of when fertility treatment is appropriate and whether pregnancy is medically recommended.

How Different Cancer Treatments Affect IVF

Cancer treatments can affect egg supply, the ability to carry a pregnancy or both. The effects depend on:

The drugs used
Radiation location and dose
Surgeries performed
Your age when you received treatment

For IVF after cancer treatment, the location of treatment-related damage matters.

Ovarian damage can reduce the number of eggs available for retrieval. Damage to the uterus can affect implantation or the ability to safely continue a pregnancy even when viable embryos are available.

A gestational surrogate may address the second problem because the embryo is transferred to the surrogate rather than the intended parent.

Surrogacy doesn’t restore ovarian reserve or improve egg or embryo quality.

Chemotherapy and IVF

Chemotherapy can damage eggs in the ovaries and reduce ovarian reserve, which can affect IVF response and success.

Depending on the medication, dose and your individual response, ovarian function may be temporarily suppressed or permanently reduced.

Some chemotherapy medications pose greater fertility risks than others. Alkylating agents are associated with a particularly high risk of ovarian damage, and risk generally increases with greater cumulative exposure to treatments that affect the ovaries.

Your oncology records can help a reproductive endocrinologist evaluate the drugs and doses you actually received.

Determining if pregnancy after chemo and radiation is viable for your situation also help you understand how treatment may affect your fertility and pregnancy after treatment ends.

Age at treatment affects the outlook because ovarian reserve naturally decreases with age. A younger person generally begins treatment with more eggs and therefore may have more ovarian reserve remaining afterward, although age doesn’t prevent treatment-related infertility.

After chemotherapy, anti-Müllerian hormone (AMH) testing and an antral follicle count (AFC) can help estimate remaining ovarian reserve.

These tests can help your fertility specialist plan ovarian stimulation, but they don’t directly measure egg quality or predict whether IVF will result in a live birth.

Pelvic Radiation

Pelvic radiation can affect both ovarian function and the uterus, potentially changing your ability to create embryos and carry a pregnancy. The amount of damage depends in part on the radiation dose, treatment field and age at treatment.

Radiation that reaches the ovaries can reduce the number of eggs that remain.

Your fertility specialist will need the location and dose of radiation to assess likely ovarian damage, while ovarian reserve testing can estimate egg supply but can’t directly measure the quality of the remaining eggs.

Radiation involving the uterus can cause scarring and affect uterine tissue, muscle and blood flow.

Understanding pregnancy after pelvic radiation is especially relevant when evaluating these uterine effects because treatment can be associated with higher risks of miscarriage, preterm birth and low birth weight.

For some intended parents, IVF may still produce embryos even though carrying the pregnancy is no longer considered safe or advisable.

If your doctors identify uterine damage as the main obstacle, an embryo may instead be transferred to a gestational surrogate.

IVF Success After Ovarian Cancer

IVF after ovarian cancer can be possible when treatment preserves enough ovarian function.

There isn’t one useful IVF success rate for all ovarian cancer survivors because the chances of success depend on your age, remaining ovarian reserve, cancer type, surgery and any additional treatment you received.

For selected early-stage ovarian cancers, fertility-sparing surgery may preserve the uterus and one ovary rather than removing both ovaries and the uterus.

Whether this approach is appropriate depends on the cancer’s type, stage and other clinical findings and should be determined by your oncology team.

Preserving an ovary doesn’t guarantee normal ovarian reserve. Surgery and other cancer treatments may leave fewer eggs available, which can reduce the number retrieved during an IVF cycle and the number of embryos available for transfer.

Concerns about ovarian stimulation and cancer recurrence also need an individualized review.

When evaluating ovarian cancer and surrogacy, first determine whether ovarian function, the ability to carry a pregnancy or both have been affected. Surrogacy can address a carrying problem, but it can’t restore ovarian function.

If your uterus can carry a pregnancy but your ovaries no longer produce usable eggs, donor eggs may be an option. Eggs or embryos frozen before treatment may provide another option if you preserved them.

IVF After Cervical Cancer

IVF after cervical cancer may be possible if treatment preserved ovarian function.

Pregnancy may also be possible if your uterus was preserved, but whether you can safely carry depends on the treatment you received and how it affected your cervix and uterus.

A radical trachelectomy removes the cervix while preserving the uterus and may allow pregnancy after treatment for appropriately selected patients.

Because the uterus remains, IVF and embryo transfer may still be options when ovarian function and other medical factors allow.

Removing the cervix can increase the risk of cervical insufficiency, in which the remaining cervical support may not be able to maintain a pregnancy as effectively. This can increase the risk of pregnancy loss and preterm birth, so pregnancy after a trachelectomy generally requires individualized obstetric evaluation.

A hysterectomy creates a different limitation.

Once the uterus has been removed, an embryo can’t be transferred to you. If your ovaries were preserved and still function, you may be able to retrieve eggs, create embryos through IVF and transfer an embryo to a gestational surrogate.

These treatment differences are central to understanding cervical cancer and surrogacy. Pelvic radiation, for example, may leave the uterus in place while damaging it enough that pregnancy becomes substantially riskier.

A fertility specialist can evaluate IVF potential, while your oncology and maternal-fetal medicine teams can assess whether carrying is medically appropriate.

That gives you a medical basis for deciding whether carrying a pregnancy or gestational surrogacy is worth considering.

How Long Should You Wait Before IVF After Cancer?

There is no single waiting period for IVF after cancer treatment.

Your timeline depends on your cancer type, recurrence risk, treatment history and whether you are still taking medications that affect pregnancy or fertility treatment.

The American Cancer Society’s information about pregnancy after cancer treatment explains why timing recommendations can differ.

Some cancer care providers recommend waiting at least six months after chemotherapy before becoming pregnant, while in other circumstances doctors may recommend waiting two to five years because recurrence risk for some cancers is higher during the first several years after treatment.

The recommended wait is different from person to person because these timeframes address different medical concerns.

A longer wait may relate to recurrence monitoring or continued cancer therapy rather than whether your ovaries are capable of responding to IVF.

If fertility timing matters, ask whether your recommended waiting period applies to ovarian stimulation and egg retrieval, pregnancy or both. Your oncologist and reproductive endocrinologist can then coordinate a plan based on the treatment you actually received and your current cancer care.

What Tests Can Show Whether IVF Is Still an Option?

AMH, FSH, estradiol, antral follicle count, ultrasound and uterine evaluation can help determine whether IVF after cancer treatment remains an option.

No single test can predict IVF success, so fertility specialists interpret these results together with your age, treatment history and reproductive anatomy.

Common parts of the evaluation include:

AMH (anti-Müllerian hormone): Estimates ovarian reserve. A lower result can indicate fewer remaining eggs, but AMH doesn’t directly measure egg quality.
FSH (follicle-stimulating hormone): Often measured early in the menstrual cycle. Higher levels can be associated with diminished ovarian reserve.
Estradiol: Often measured with FSH because the estradiol level can affect how an early-cycle FSH result is interpreted.
Antral follicle count (AFC): A transvaginal ultrasound counts small follicles in the ovaries and helps estimate how the ovaries may respond to stimulation.
Pelvic ultrasound: Allows your fertility specialist to examine your ovaries, uterus and other reproductive structures after treatment.
Uterine evaluation: Depending on your cancer treatment, your clinic may examine the uterine cavity and other factors that affect embryo transfer and pregnancy.
Partner testing: If embryos will be created with a partner’s sperm, semen analysis and other indicated testing can identify additional fertility factors.

More detailed fertility testing after cancer can help your medical team determine whether treatment primarily affected ovarian function, pregnancy potential or both.

If viable embryos are available but your uterus can’t safely support a pregnancy, gestational surrogacy may address that specific problem. If creating viable embryos is the main difficulty, your fertility specialist can discuss whether another retrieval, preserved eggs or embryos, or donor eggs makes more sense.

When Is Surrogacy Recommended After Cancer?

Doctors may recommend considering gestational surrogacy after cancer when carrying a pregnancy is impossible or poses a level of medical risk they advise against, but viable embryos can still be created or are already frozen.

It is most likely to address the underlying problem when carrying the pregnancy, rather than creating the embryo, is the main medical obstacle.

Common situations include:

Your uterus was removed during cancer treatment.
Pelvic radiation caused uterine damage that makes carrying a pregnancy medically inadvisable.
Surgery involving the cervix or uterus created pregnancy risks your doctors consider too high.
You have frozen embryos but have been advised not to become pregnant.
Your ovaries still produce eggs, but your uterus can no longer safely support a pregnancy.
Ongoing treatment or another cancer-related health concern makes pregnancy inadvisable.

Guidance on family-building options after cancer can help put these situations in context because cancer treatment can affect ovarian function and the ability to carry in different ways.

Having one of these circumstances doesn’t by itself determine that you need a gestational surrogate.

Your fertility specialist, oncologist and, when appropriate, a maternal-fetal medicine physician can assess the pregnancy risk and explain what alternatives remain available.

Surrogacy is less likely to solve the problem when embryo creation is the main obstacle. If diminished ovarian reserve or egg quality is preventing the creation of viable embryos, transferring an embryo to a gestational surrogate doesn’t change its quality.

The next discussion may instead focus on IVF strategy, previously frozen eggs or embryos, or donor eggs.

Why IVF With a Gestational Surrogate May Improve Your Chances

IVF with a gestational surrogate may improve the chance of achieving a pregnancy when your embryos are viable but your uterus or health makes carrying difficult or unsafe.

It doesn’t improve ovarian reserve, egg quality or embryo quality.

For example, you may have embryos frozen before cancer treatment but later undergo a hysterectomy. Those embryos can no longer be transferred to you, but they may be transferred to a medically screened gestational surrogate.

The same option may be considered if you can retrieve eggs after treatment but pelvic radiation left your uterus unable to safely support a pregnancy.

The American Cancer Society’s overview of fertility assistance after cancer provides additional context on reproductive options available after cancer treatment.

The calculation is different if IVF isn’t producing viable embryos. A gestational surrogate can’t improve ovarian reserve, egg quality or embryo quality. Your fertility specialist may instead recommend a different IVF approach, eggs or embryos preserved before cancer treatment, or donor eggs.

Before comparing another embryo transfer with gestational surrogacy, ask your fertility specialist what is limiting your current treatment: creating a viable embryo or carrying the pregnancy.

That answer tells you whether gestational surrogacy addresses the reason treatment has not worked.

Can You Still Have a Biological Child After a Hysterectomy?

Yes. You may still be able to have a genetically related child after a hysterectomy if your ovaries continue to produce usable eggs or you froze eggs or embryos before surgery.

Because the uterus has been removed, a gestational surrogate would need to carry the pregnancy.

A radical hysterectomy performed for cancer removes the uterus and cervix and can involve nearby tissue. The ovaries may or may not be removed, depending on the cancer and treatment plan.

If one or both ovaries remain and function well enough for IVF, a fertility specialist may be able to retrieve eggs and create embryos after surgery.

If you already froze embryos, they may be available for transfer to a gestational surrogate without another egg retrieval.

Your specific hysterectomy and surrogacy options depend in large part on whether ovarian function or preserved eggs or embryos remain. Frozen eggs may be thawed and fertilized to create embryos, while donor eggs may be considered if ovarian function was lost and no eggs or embryos were preserved.

Your operative report and fertility preservation records can show exactly what was removed and what eggs or embryos remain available.

A reproductive endocrinologist can use that information to determine which options are medically possible.

Talk With a Surrogacy Professional About Your Family-Building Options

A conversation about surrogacy becomes most useful when your medical team identifies carrying a pregnancy as the main obstacle.

At that point, you can find out how IVF with a gestational surrogate would work with the embryos, eggs and medical circumstances you have.

Through Surrogate.com, you can connect with surrogacy professionals and learn when gestational surrogacy may be medically appropriate. You can also compare what agencies offer, how surrogate screening works and which costs and financial protections deserve closer review.

If you begin comparing agencies, ask what medical and psychological screening occurs before matching and when a surrogate is considered pre-screened.

Also compare total cost, how escrow is handled, what a rematching policy covers and what happens financially if a match or embryo transfer doesn’t move forward.

Surrogacy is most relevant after cancer when it addresses a problem IVF alone can’t solve: being unable to safely carry a pregnancy.

Once your medical team has identified that barrier, a surrogacy professional can explain how the process would apply to your circumstances so you can decide whether it makes sense for your family-building plans.

Find Out More